IT8521447A0 - NEW CITIDIN-DIPHOSPHOCHOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE. - Google Patents
NEW CITIDIN-DIPHOSPHOCHOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE.Info
- Publication number
- IT8521447A0 IT8521447A0 IT8521447A IT2144785A IT8521447A0 IT 8521447 A0 IT8521447 A0 IT 8521447A0 IT 8521447 A IT8521447 A IT 8521447A IT 2144785 A IT2144785 A IT 2144785A IT 8521447 A0 IT8521447 A0 IT 8521447A0
- Authority
- IT
- Italy
- Prior art keywords
- citidin
- diphosphocholine
- new
- particularly suitable
- oral use
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21447/85A IT1188178B (en) | 1985-07-05 | 1985-07-05 | CITIDIN-DIPHOSPOCOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE |
AT86108677T ATE62250T1 (en) | 1985-07-05 | 1986-06-25 | CYTIDINE-DIPHOSPHOCHOLINE SALTS, PARTICULARLY SUITABLE FOR ORAL USE. |
EP86108677A EP0207436B1 (en) | 1985-07-05 | 1986-06-25 | New cytidine-diphosphocholine salts, particularly suitable for oral use |
DE8686108677T DE3678498D1 (en) | 1985-07-05 | 1986-06-25 | CYTIDINE-DIPHOSPHOCHOLINE SALTS, ESPECIALLY SUITABLE FOR ORAL USE. |
US06/878,697 US4789666A (en) | 1985-07-05 | 1986-06-26 | Cytidine-diphosphocholine salts, particularly suitable for oral use |
JP61156325A JPS6212794A (en) | 1985-07-05 | 1986-07-04 | Novel cytidine phosphocholine salt especially suitable for oral use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21447/85A IT1188178B (en) | 1985-07-05 | 1985-07-05 | CITIDIN-DIPHOSPOCOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8521447A0 true IT8521447A0 (en) | 1985-07-05 |
IT1188178B IT1188178B (en) | 1988-01-07 |
Family
ID=11181915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT21447/85A IT1188178B (en) | 1985-07-05 | 1985-07-05 | CITIDIN-DIPHOSPOCOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE |
Country Status (6)
Country | Link |
---|---|
US (1) | US4789666A (en) |
EP (1) | EP0207436B1 (en) |
JP (1) | JPS6212794A (en) |
AT (1) | ATE62250T1 (en) |
DE (1) | DE3678498D1 (en) |
IT (1) | IT1188178B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0408668B1 (en) * | 1988-10-27 | 1994-05-11 | Massachusetts Institute Of Technology | Process for increasing phosphatidylcholine in vivo |
KR0177841B1 (en) * | 1992-01-30 | 1999-04-01 | 나까무라 간노스께 | Process for producing cytidine diphosphate choline |
US5482706A (en) * | 1992-04-17 | 1996-01-09 | Takeda Chemical Industries, Ltd. | Transmucosal therapeutic composition |
EP1041992A4 (en) * | 1997-12-24 | 2007-05-09 | Ferrer Int | Hyperhydrated citicoline, process and use |
US6472378B2 (en) * | 1998-08-31 | 2002-10-29 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
US7915233B1 (en) | 1998-08-31 | 2011-03-29 | Wellstat Therapeutics Corporation | Compositions and methods for treatment of mitochondrial diseases |
US7807654B2 (en) * | 1998-08-31 | 2010-10-05 | Wellstat Therapeutics Corporation | Compositions and methods for treatment of mitochondrial diseases |
US6924272B2 (en) * | 2001-09-05 | 2005-08-02 | Yamasa Corporation | Medicinal composition for diabetic neuropathy |
JPWO2004006940A1 (en) * | 2002-07-11 | 2005-11-10 | ヤマサ醤油株式会社 | Pharmaceutical composition for drug-induced neuropathy |
BRPI0510857A (en) * | 2004-05-13 | 2007-12-26 | Massachusetts Inst Technology | effects of uridine on dopamine release |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3666748A (en) * | 1967-12-18 | 1972-05-30 | Takeda Chemical Industries Ltd | Method for production of cytidine (or deoxycytidine)-5{40 -diphosphate choline and intermediates therefor |
NL149812B (en) * | 1969-04-24 | 1976-06-15 | Takeda Chemical Industries Ltd | PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR PREPARING CRYSTALLINE CYTIDINE-5'-DIPHOSPHATE-CHOLINE-MONOHYDRATE. |
JPS5517769B2 (en) * | 1972-01-10 | 1980-05-14 | ||
JPS6043078B2 (en) * | 1980-10-31 | 1985-09-26 | 株式会社興人 | Production method of choline cytidine diphosphate |
CA1188998A (en) * | 1980-11-12 | 1985-06-18 | Stephen R. Ash | System and method for controlling and monitoring blood or biologic fluid flow |
JPS6043079B2 (en) * | 1980-12-25 | 1985-09-26 | 株式会社興人 | Method for producing choline cytidine diphosphate |
IT1177373B (en) * | 1984-12-06 | 1987-08-26 | Bioresearch Spa | SALTS OF 5'-METHYLLIUM-5'-DEOXYDENOSINE WITH LONG ALCHYLIC CHAIN SULPHONIC ACIDS |
-
1985
- 1985-07-05 IT IT21447/85A patent/IT1188178B/en active
-
1986
- 1986-06-25 DE DE8686108677T patent/DE3678498D1/en not_active Expired - Fee Related
- 1986-06-25 AT AT86108677T patent/ATE62250T1/en not_active IP Right Cessation
- 1986-06-25 EP EP86108677A patent/EP0207436B1/en not_active Expired - Lifetime
- 1986-06-26 US US06/878,697 patent/US4789666A/en not_active Expired - Fee Related
- 1986-07-04 JP JP61156325A patent/JPS6212794A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
EP0207436A2 (en) | 1987-01-07 |
IT1188178B (en) | 1988-01-07 |
JPH0217559B2 (en) | 1990-04-20 |
ATE62250T1 (en) | 1991-04-15 |
EP0207436A3 (en) | 1988-01-27 |
DE3678498D1 (en) | 1991-05-08 |
JPS6212794A (en) | 1987-01-21 |
US4789666A (en) | 1988-12-06 |
EP0207436B1 (en) | 1991-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3650082D1 (en) | ORAL Vaccines. | |
IT8648450A0 (en) | ANTI-TARTAR ORAL COMPOSITION | |
IT8648451A0 (en) | ANTI-TARTAR ORAL COMPOSITION | |
DK190986A (en) | IMIDAZOQUINOLINE DERIVATIVES | |
IT8719977A0 (en) | PHARMACEUTICALLY ACCEPTABLE, IMPROVED AMLODIPE SALTS. | |
IT8420938A0 (en) | STABLE SALTS OF SULFO-ADENOSYL-L-METHIONINE (SAME) PARTICULARLY SUITABLE FOR PARENTERAL USE. | |
IT8420940A0 (en) | STABLE SALTS OF SULFO-ADENOSYL-L-METHIONINE (SAME) PARTICULARLY SUITABLE FOR ORAL PHARMACEUTICAL USE. | |
DE3571437D1 (en) | PYRAZOLOPYRIDINE DERIVATIVES | |
DK161428C (en) | SOLID, ORAL CARIAL EFFECTS | |
IT8521447A0 (en) | NEW CITIDIN-DIPHOSPHOCHOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE. | |
DE3688182D1 (en) | ORAL COMPOSITION. | |
IT8322621A0 (en) | THERAPEUTIC COMPOSITIONS FOR ORAL USE CONTAINING STABLE SALTS OF S-ADENOSYL-L-METHIONINE. | |
ES555778A0 (en) | EQUIPMENT FOR DENTAL USE. | |
IT8521445A0 (en) | NEW CARNITINE SALTS PARTICULARLY SUITABLE FOR ORAL USE. | |
NO862403D0 (en) | Glycerol derivatives. | |
FI861394A (en) | OVER ANCHORING FOR EXHAUST. | |
IT8521214A0 (en) | SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE. | |
FI850427A0 (en) | STYRNINGSMETOD FOER PANNANLAEGGNING SOM FUNGERAR MED FAST BRAENSLE OCH MOTSVARANDE STYRANLAEGGNING. | |
FI863835A0 (en) | SPIRALLEDNING MED EN KRING LEDNINGEN LINDAD FYLLSPIRAL. | |
DK246986D0 (en) | SUBSTITUTED BENZISOINDOLO ISOQUINOLIN DERIVATIVES | |
DE3689338D1 (en) | Isocarbacyclin derivatives. | |
IT8647748A0 (en) | ANTI-TARTAR ORAL COMPOSITION | |
IT8620676A0 (en) | PROCEDURE FOR THE PREPARATION OF HEPARIN SALTS. | |
IT8519875A0 (en) | CARNITINE SALTS. | |
BR8504976A (en) | ARTICULATOR FOR DENTAL USE |